First National Trust Co Has $23.92 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

First National Trust Co decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 40,913 shares of the healthcare conglomerate’s stock after selling 864 shares during the period. UnitedHealth Group accounts for 0.9% of First National Trust Co’s investment portfolio, making the stock its 26th biggest holding. First National Trust Co’s holdings in UnitedHealth Group were worth $23,921,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the third quarter valued at $27,000. Macroview Investment Management LLC grew its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $31,000. Finally, Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 1.5 %

UnitedHealth Group stock opened at $625.25 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $575.41 billion, a P/E ratio of 40.73, a P/E/G ratio of 1.81 and a beta of 0.58. The business has a 50-day simple moving average of $581.93 and a two-hundred day simple moving average of $545.85. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $6.56 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Ratings Changes

Several analysts have recently weighed in on UNH shares. Barclays lowered their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Stephens lowered their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Argus increased their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.